Enabling early detection of osteoarthritis from presymptomatic cartilage texture maps via transport-based learning.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published Date:

Abstract

Many diseases have no visual cues in the early stages, eluding image-based detection. Today, osteoarthritis (OA) is detected after bone damage has occurred, at an irreversible stage of the disease. Currently no reliable method exists for OA detection at a reversible stage. We present an approach that enables sensitive OA detection in presymptomatic individuals. Our approach combines optimal mass transport theory with statistical pattern recognition. Eighty-six healthy individuals were selected from the Osteoarthritis Initiative, with no symptoms or visual signs of disease on imaging. On 3-y follow-up, a subset of these individuals had progressed to symptomatic OA. We trained a classifier to differentiate progressors and nonprogressors on baseline cartilage texture maps, which achieved a robust test accuracy of 78% in detecting future symptomatic OA progression 3 y prior to symptoms. This work demonstrates that OA detection may be possible at a potentially reversible stage. A key contribution of our work is direct visualization of the cartilage phenotype defining predictive ability as our technique is generative. We observe early biochemical patterns of fissuring in cartilage that define future onset of OA. In the future, coupling presymptomatic OA detection with emergent clinical therapies could modify the outcome of a disease that costs the United States healthcare system $16.5 billion annually. Furthermore, our technique is broadly applicable to earlier image-based detection of many diseases currently diagnosed at advanced stages today.

Authors

  • Shinjini Kundu
    Department of Radiology, The Johns Hopkins Hospital, Baltimore, MD USA.
  • Beth G Ashinsky
    Laboratory of Clinical Investigation, Magnetic Resonance Imaging and Spectroscopy Section, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore 21224, Maryland.
  • Mustapha Bouhrara
    Laboratory of Clinical Investigation, Magnetic Resonance Imaging and Spectroscopy Section, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore 21224, Maryland.
  • Erik B Dam
    Department of Computer Science, University of Copenhagen, 2100 Copenhagen, Denmark.
  • Shadpour Demehri
    Department of Radiology, The Johns Hopkins Hospital, Baltimore, MD 21287.
  • Mohammad Shifat-E-Rabbi
    Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
  • Richard G Spencer
    Laboratory of Clinical Investigation, Magnetic Resonance Imaging and Spectroscopy Section, National Institute on Aging, NIH, 251 Bayview Boulevard, Baltimore 21224, Maryland.
  • Kenneth L Urish
    Bone and Joint Center, Magee Women's Hospital, Department of Orthopaedic Surgery, Pittsburgh, Pennsylvania.
  • Gustavo K Rohde
    Imaging and Data Science Laboratory Department of Biomedical Engineering Department of Electrical and Computer Engineering University of Virginia.